Applicator devices for coating medical devices with a liquid
Applicators with absorbent elements and attachment mechanisms apply coatings to catheters during insertion, addressing degradation issues and ensuring uniform application, thereby reducing clinical complications.
Patent Information
- Application Number
- PCT/US2026/027372
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Existing catheter coatings degrade during storage or exposure to air, and applying them manually at the bedside complicates sterile technique and is inconsistent, while integrating coating application into clinical workflows is challenging.
Applicators with absorbent elements are designed to apply liquids to catheters during insertion through introducer sheaths or endoscopes, featuring attachment mechanisms and longitudinally divisible designs to ensure uniform coating application without disrupting standard clinical procedures.
Preserves coating integrity by applying liquids at the point of use, ensuring uniform and consistent application compatible with existing clinical workflows, reducing complications like infections and thrombosis.
Smart Images

Figure US2026027372_12112026_PF_FP_ABST
Abstract
Description
[0001] Attorney Docket No. 11583-028WO1
[0002] APPLICATOR DEVICES FOR COATING MEDICAL DEVICES WITH A LIQUID
[0003] STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
[0004] This invention was made with government support under Grant No. 5R44DK135256-02 awarded by the National Institutes of Health. The government has certain rights in the invention.
[0005] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority to, and the benefit of, U.S. Provisional Application No. 63 / 802,092 filed on May 8, 2025, the disclosure of which is hereby expressly incorporated by reference herein in its entirety.
[0006] FIELD OF THE DISCLOSURE
[0007] The present disclosure relates to applicator devices for coating medical devices, and more particularly to applicators configured to apply a liquid onto the surface of a catheter during insertion through an introducer sheath or endoscope.
[0008] BACKGROUND
[0009] Medical catheters are widely used in clinical settings for vascular access, drainage, and delivery of therapeutic agents. Catheters may remain in place for extended periods, during which time they are exposed to biological fluids and tissues.
[0010] Complications associated with indwelling catheters include infections, thrombosis, and biological fouling. These complications can lead to adverse patient outcomes and may require catheter removal or replacement, additional medical interventions, or extended hospital stays.
[0011] Surface treatments and coatings have been explored as approaches to reduce biological adhesion and mitigate catheter-related complications. Some surface treatments involve applying liquid layers or coatings to catheter surfaces. However, such coatings may degrade during storage or upon exposure to air, potentially reducing their effectiveness by the time the catheter is placed in a patient.Attorney Docket No. 11583-028WO1
[0012] Applying a coating to a catheter at the point of use, immediately before or during catheter placement, may help preserve coating integrity. However, integrating such an application step into standard clinical workflows presents challenges. Clinicians typically work within timesensitive environments and may have limited ability to perform additional preparation steps without disrupting established procedures.
[0013] Introducer sheaths and endoscopes are commonly used to facilitate catheter placement. These devices provide a pathway through which catheters are advanced into the body. Devices or methods that can apply coatings to catheters during the insertion process, while remaining compatible with existing introducer sheaths and endoscopes, may offer advantages in clinical settings.
[0014] Accordingly, there remains interest in devices and methods for applying liquids to catheter surfaces in a manner that integrates with standard clinical workflows and preserves coating efficacy.
[0015] SUMMARY OF THE DISCLOSURE
[0016] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
[0017] Described herein are applicators for applying a liquid to an external surface of medical devices such as catheters. These applicators can include an applicator body defining an internal lumen sized to receive the catheter therethrough, at least one absorbent element disposed within the internal lumen and configured to absorb the liquid, and an attachment mechanism configured to secure the applicator body to an introducer sheath or an endoscope. The absorbent element can be positioned to contact an external surface of the catheter as the catheter is advanced through the internal lumen, thereby applying the liquid absorbed by the absorbent element to the external surface of the catheter.
[0018] In some embodiments, the applicator body is longitudinally divisible to permit removal of the applicator body from around a catheter received within the internal lumen. The applicator body may include a splitting mechanism comprising at least one of a score line, a peel tab, or a living hinge to facilitate longitudinal division. The applicator can further include at least one end cap configured to retain the absorbent element within the applicator body, with the end capAttorney Docket No. 11583-028WO1
[0019] optionally being reversibly attachable to the applicator body and, in some embodiments, itself longitudinally divisible.
[0020] In some embodiments, the absorbent element is adhered to an inner surface of the applicator body. The attachment mechanism can comprise a threaded coupling, a friction-fit collar, a snap-fit coupling, a clamp, or a combination thereof. The attachment mechanism may be configured to secure the applicator body to the introducer sheath or endoscope such that the internal lumen of the applicator body is aligned with a lumen passing longitudinally through the introducer sheath or endoscope.
[0021] In some embodiments, the at least one absorbent element comprises an open-cell foam, such as an open-cell polyurethane foam. The absorbent element can extend along a longitudinal length of the internal lumen sufficient to simultaneously contact a plurality of circumferential locations on the external surface of the catheter, thereby applying a substantially uniform coating of the liquid to the external surface of the catheter. In certain versions, the absorbent element is pre-saturated with the liquid prior to sterilization and packaging of the applicator.
[0022] The applicator body can be formed from a thermoplastic, such as polypropylene, polyvinyl chloride, polyethylene, polycarbonate, acrylonitrile butadiene styrene (ABS), or combinations thereof. The liquid can comprise a lubricating fluid, an antimicrobial solution, an anticoagulant solution, saline, or a combination thereof. In some embodiments, the liquid comprises a liquid perfluorocarbon, such as perfluorotributylamine, perfluorooctyl bromide, perfluorodecalin, perfluoroperhydrophenanthrene, perfluorohexane, perfluorotripropylamine, dichloroperfluoro-n-octane, perfluoromethylcyclohexane, perfluorooctane, pentafluorophenyl, or a combination thereof. In other embodiments, the liquid comprises polydimethylsiloxane (PDMS) oil, for example PDMS oil having a viscosity from about 10 centipoise to about 10,000 centipoise.
[0023] In some embodiments, the external surface of the catheter comprises a roughened solid surface and the liquid comprises a lubricating fluid. Applying the liquid absorbed by the absorbent element to the external surface of the catheter can form a lubricating fluid layer adhering to and preferentially wetting the roughened solid surface to form a slippery liquid surface over the roughened solid surface. The catheter may comprise a vascular access catheter, a central venous catheter, a dialysis catheter, or a stent delivery catheter.
[0024] In some embodiments, the applicator further includes a detachable cap sized to seal a distal end of the internal lumen. The applicator can be configured as a single-use sterile device.Attorney Docket No. 11583-028WO1
[0025] Also described herein are sterile kits that include an applicator as described herein, a tray comprising a recess configured to temporarily hold the applicator, and a sterile barrier enclosing at least the applicator and the tray. In some embodiments, the kit further includes a catheter sized to pass through the internal lumen of the applicator body and an introducer sheath or an endoscope. The recess may be configured to hold the applicator in an upright orientation for saturating the absorbent element with the liquid. In some embodiments, the recess includes an alignment feature configured to position the applicator relative to a liquid source and may comprise at least one of a snap-fit holder, a friction-fit holder, or a channel-shaped holder.
[0026] Also described herein are methods of applying a liquid to an external surface of a catheter. These methods can include saturating the absorbent element of an applicator as described herein with a liquid, securing the applicator to an introducer sheath or an endoscope via the attachment mechanism, and advancing at least a portion of the catheter through the internal lumen of the applicator such that the external surface of the catheter contacts the absorbent element and the liquid is applied to the external surface of the catheter during advancement through the internal lumen. The method can further include detaching the applicator from the introducer sheath or the endoscope after the catheter is advanced and removing the applicator from around the catheter. In embodiments where the applicator body is longitudinally divisible, removing the applicator from around the catheter can comprise longitudinally dividing the applicator body to remove the applicator body from around the catheter. In some implementations, saturating the absorbent element with the liquid comprises positioning the applicator body in a recess of a tray configured to temporarily hold the applicator body and introducing the liquid into the internal lumen while the applicator body is supported by the recess, optionally with the recess holding the applicator body in an upright orientation during introduction of the liquid.
[0027] The foregoing general description of the illustrative embodiments and the following detailed description thereof are merely exemplary aspects of the teachings of this disclosure and are not restrictive.
[0028] BRIEF DESCRIPTION OF THE DRAWINGS
[0029] The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects described below.
[0030] Figure 1 is a perspective view of an example applicator described herein.Attorney Docket No. 11583-028WO1
[0031] Figure 2 is an exploded view of an example applicator described herein.
[0032] DETAILED DESCRIPTION
[0033] The following description of the disclosure is provided as an enabling teaching of the disclosure in its best, currently known embodiments. Many modifications and other embodiments disclosed herein will come to mind to one skilled in the art to which the disclosed compositions and methods pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the disclosures are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. The skilled artisan will recognize many variants and adaptations of the aspects described herein. These variants and adaptations are intended to be included in the teachings of this disclosure and to be encompassed by the claims herein.
[0034] Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.
[0035] As can be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.
[0036] Any recited method can be carried out in the order of events recited or in any other order that is logically possible. That is, unless otherwise expressly stated, it is in no way intended that any method or aspect set forth herein be construed as requiring that its steps be performed in a specific order. Accordingly, where a method claim does not specifically state in the claims or descriptions that the steps are to be limited to a specific order, it is no way intended that an order be inferred, in any respect. This holds for any possible non-express basis for interpretation, including matters of logic with respect to arrangement of steps or operational flow, plain meaning derived from grammatical organization or punctuation, or the number or type of aspects described in the specification.
[0037] All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and / or materials in connection with which the publications are cited. The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the presentAttorney Docket No. 11583-028WO1
[0038] invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided herein can be different from the actual publication dates, which can require independent confirmation.
[0039] It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the disclosed compositions and methods belong. It can be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the specification and relevant art and should not be interpreted in an idealized or overly formal sense unless expressly defined herein.
[0040] Prior to describing the various aspects of the present disclosure, the following definitions are provided and should be used unless otherwise indicated. Additional terms may be defined elsewhere in the present disclosure.
[0041] Definitions
[0042] As used herein, “comprising” is to be interpreted as specifying the presence of the stated features, integers, steps, or components as referred to, but does not preclude the presence or addition of one or more features, integers, steps, or components, or groups thereof. Moreover, each of the terms “by”, “comprising,” “comprises”, “comprised of,” “including,” “includes,” “included,” “involving,” “involves,” “involved,” and “such as” are used in their open, non¬ limiting sense and may be used interchangeably. Further, the term “comprising” is intended to include examples and aspects encompassed by the terms “consisting essentially of’ and “consisting of.” Similarly, the term “consisting essentially of’ is intended to include examples encompassed by the term “consisting of.”
[0043] As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a compound”, “a composition”, or “a disorder”, includes, but is not limited to, two or more such compounds, compositions, or disorders, and the like.
[0044] It should be noted that ratios, concentrations, amounts, and other numerical data can be expressed herein in a range format. It can be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. It is also understood that there are a number of values disclosed herein, and that eachAttorney Docket No. 11583-028WO1
[0045] value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Ranges can be expressed herein as from “about” one particular value, and / or to “about” another particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it can be understood that the particular value forms a further aspect. For example, if the value “about 10” is disclosed, then “10” is also disclosed.
[0046] When a range is expressed, a further aspect includes from the one particular value and / or to the other particular value. For example, where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure, e.g., the phrase “x to y” includes the range from ‘x’ to ‘y’ as well as the range greater than ‘x’ and less than ‘y’. The range can also be expressed as an upper limit, e.g., ‘about x, y, z, or less’ and should be interpreted to include the specific ranges of ‘about x’, ‘about y’, and ‘about z’ as well as the ranges of ‘less than x’, less than y’, and ‘less than z’. Likewise, the phrase ‘about x, y, z, or greater’ should be interpreted to include the specific ranges of ‘about x’, ‘about y’, and ‘about z’ as well as the ranges of ‘greater than x’, greater than y’, and ‘greater than z’. In addition, the phrase “about ‘x’ to ‘y’”, where ‘x’ and ‘y’ are numerical values, includes “about ‘x’ to about ‘y’”.
[0047] It is to be understood that such a range format is used for convenience and brevity, and thus, should be interpreted in a flexible manner to include not only the numerical values explicitly recited as the limits of the range, but also to include all the individual numerical values or sub-ranges encompassed within that range as if each numerical value and sub-range is explicitly recited. To illustrate, a numerical range of “about 0.1% to 5%” should be interpreted to include not only the explicitly recited values of about 0.1% to about 5%, but also include individual values (e.g., about 1%, about 2%, about 3%, and about 4%) and the sub-ranges (e.g., about 0.5% to about 1.1%; about 5% to about 2.4%; about 0.5% to about 3.2%, and about 0.5% to about 4.4%, and other possible sub-ranges) within the indicated range.
[0048] As used herein, the terms “about,” “approximate,” “at or about,” and “substantially” mean that the amount or value in question can be the exact value or a value that provides equivalent results or effects as recited in the claims or taught herein. That is, it is understood that amounts, sizes, formulations, parameters, and other quantities and characteristics are not and need not be exact but may be approximate and / or larger or smaller, as desired, reflecting tolerances, conversion factors, rounding off, measurement error and the like, and other factorsAttorney Docket No. 11583-028WO1
[0049] known to those of skill in the art such that equivalent results or effects are obtained. In some circumstances, the value that provides equivalent results or effects cannot be reasonably determined. In such cases, it is generally understood, as used herein, that “about” and “at or about” mean the nominal value indicated ±10% variation unless otherwise indicated or inferred. In general, an amount, size, formulation, parameter or other quantity or characteristic is “about,” “approximate,” or “at or about” whether or not expressly stated to be such. It is understood that where “about,” “approximate,” or “at or about” is used before a quantitative value, the parameter also includes the specific quantitative value itself, unless specifically stated otherwise. As used herein, the term “substantially free,” when used in the context of a composition or component of a composition that is substantially absent, is intended to refer to an amount that is then about 1 % by weight or less, e.g., less than about 0.5 % by weight, less than about 0.1 % by weight, less than about 0.05 % by weight, or less than about 0.01 % by weight of the stated material, based on the total weight of the composition.
[0050] The disclosure herein relates to the point-of-use application of liquids, such as lubricants, antimicrobial agents, and anticoagulant solutions, to surfaces of medical devices, including catheters. In clinical practice, catheters are often inserted through introducer sheaths or endoscopes. Surface treatments that are applied well in advance of use can be degraded by storage conditions, evaporation, or handling, while manual liquid application at the bedside can be inconsistent and can complicate sterile technique. There is therefore a technical interest in solutions that can provide a controlled and substantially uniform liquid coating on a variety of catheter types immediately before or during insertion, in a manner that can be integrated with existing introducer-based workflows.
[0051] To address these considerations, certain embodiments disclosed herein provide applicators, kits, and methods in which a catheter is advanced through an applicator body that defines an internal lumen and houses at least one absorbent element configured to retain a selected liquid. The applicator body can be secured to an introducer sheath or an endoscope by way of an attachment mechanism so that, during catheter advancement, the external surface of the catheter contacts the absorbent element and acquires a liquid coating. Further embodiments include longitudinally divisible applicator bodies and associated splitting mechanisms that facilitate removal of the applicator after catheter placement, end caps and detachable caps thatAttorney Docket No. 11583-028WO1
[0052] help manage liquid containment, and tray-based recesses and alignment features that support convenient and sterile saturation of the absorbent element with a range of liquids.
[0053] Referring now to Figures 1 and 2, described herein are applicators 100 for applying a liquid to an external surface of a catheter. The applicator 100 may be configured to apply a liquid coating to a catheter at the point of use, immediately before or during catheter placement into a patient. In some cases, the applicator 100 may be attached to an introducer sheath or an endoscope, allowing the liquid to be applied to the catheter as the catheter is advanced through the applicator 100 and into the introducer sheath or endoscope. By applying the liquid at the point of use, the applicator 100 may help preserve coating integrity and reduce degradation that may otherwise occur during storage or exposure to air.
[0054] The applicator 100 may be configured to integrate with standard clinical workflows for catheter placement. In some cases, the applicator 100 may be compatible with existing introducer sheaths and endoscopes, allowing clinicians to apply liquid coatings to catheters without substantial modification to established procedures. The applicator 100 may support various liquids, including lubricating fluids, antimicrobial solutions, anticoagulant solutions, and other biocompatible liquids. In some aspects, the applicator 100 may be provided as a single-use sterile device or as part of a sterile kit.
[0055] Figure 2 illustrates an exploded view of an example applicator 100. The applicator 100 includes an applicator body 102 defining an internal lumen 104 sized to receive a catheter therethrough. The internal lumen 104 extends longitudinally through the applicator body 102 and may be configured to accommodate catheters of various diameters. In some cases, the internal lumen 104 may have a diameter selected to allow passage of a catheter while permitting contact between the catheter and an absorbent element 106 disposed within the internal lumen 104.
[0056] In some embodiments, the applicator body 102 may be formed from a thermoplastic material. By way of example, the applicator body 102 may be formed from polypropylene, polyvinyl chloride, polyethylene, polycarbonate, acrylonitrile butadiene styrene (ABS), or combinations thereof. The selection of thermoplastic material may depend on factors such as sterilization compatibility, mechanical properties, and manufacturing considerations.
[0057] In some cases, the applicator body 102 may be longitudinally divisible to permit removal of the applicator body 102 from around a catheter received within the internal lumen 104.
[0058] Longitudinal divisibility may allow the applicator body 102 to be separated and removed fromAttorney Docket No. 11583-028WO1
[0059] around the catheter after the catheter has been advanced through the applicator 100 and into an introducer sheath or endoscope, without requiring withdrawal of the catheter from the patient.
[0060] The applicator body 102 may include a splitting mechanism 112 to facilitate longitudinal division of the applicator body 102. In some aspects, the splitting mechanism 112 may comprise a score line formed along a longitudinal extent of the applicator body 102. In some cases, the splitting mechanism 112 may comprise a peel tab configured to initiate separation of the applicator body 102. In some aspects, the splitting mechanism 112 may comprise a living hinge that allows the applicator body 102 to be opened along a longitudinal axis. The splitting mechanism 112 may comprise one or more of a score line, a peel tab, or a living hinge, or combinations thereof. In some embodiments, the applicator body 102 can comprise two separate halves that are joined temporarily together via a tab or other interface.
[0061] The applicator 100 includes at least one absorbent element 106 disposed within the internal lumen 104. The absorbent element 106 is configured to absorb the liquid and to transfer the liquid to the external surface of a catheter as the catheter is advanced through the internal lumen 104. The absorbent element 106 may be positioned within the internal lumen 104 such that the absorbent element 106 contacts the external surface of the catheter during advancement of the catheter through the applicator 100.
[0062] In some aspects, the absorbent element 106 may comprise an open-cell foam. Open-cell foams may provide interconnected pore structures that facilitate absorption and retention of liquids. In some cases, the absorbent element 106 may comprise an open-cell polyurethane foam. Open-cell polyurethane foam may provide suitable liquid absorption characteristics and mechanical properties for contacting catheter surfaces during advancement through the internal lumen 104.
[0063] The absorbent element 106 may be adhered to an inner surface 114 of the applicator body 102. Adhering the absorbent element 106 to the inner surface 114 may help maintain the position of the absorbent element 106 within the internal lumen 104 during use. In some cases, the absorbent element 106 may be adhered to the inner surface 114 using an adhesive, thermal bonding, or mechanical attachment.
[0064] In some aspects, the absorbent element 106 may extend along a longitudinal length of the internal lumen 104 sufficient to simultaneously contact a plurality of circumferential locations on the external surface of the catheter. By contacting multiple circumferential locations on the catheter surface, the absorbent element 106 may apply a substantially uniform coating of theAttorney Docket No. 11583-028WO1
[0065] liquid to the external surface of the catheter as the catheter is advanced through the internal lumen 104. The longitudinal extent of the absorbent element 106 may be selected based on factors such as the desired coating thickness, the viscosity of the liquid, and the diameter of the catheter.
[0066] In some cases, the absorbent element 106 may be pre-saturated with the liquid prior to sterilization and packaging of the applicator 100. Pre-saturation may allow the applicator 100 to be provided in a ready-to-use configuration, reducing preparation steps at the point of use. In some aspects, the absorbent element 106 may be saturated with the liquid by a clinician prior to use, as described in further detail below.
[0067] The absorbent element can be dimensioned relative to the catheter such that the inner diameter of the absorbent element provides a selected degree of interference with the outer diameter of the catheter. In some embodiments, the inner diameter of the absorbent element is substantially equal to the outer diameter of the catheter (i.e., a line-to-line fit), so that the absorbent element contacts the catheter surface without substantial radial compression when the catheter is advanced through the applicator. In other embodiments, the inner diameter of the absorbent element is smaller than the outer diameter of the catheter to provide an interference fit that increases contact pressure between the absorbent element and the catheter surface and thereby promotes transfer of the liquid to the catheter.
[0068] By way of example, the interference between the inner diameter of the absorbent element and the outer diameter of the catheter can range from about 0 (line-to-line) to about 1 / 8 inch per side (corresponding to about 1 / 4 inch difference in nominal diameters), with particular embodiments employing interferences of at least about 0.005 inch, at least about 0.010 inch, or at least about 0.020 inch per side, up to about 1 / 8 inch per side. In some implementations, suitable ranges include from about 0 to about 1 / 32 inch per side, from about 1 / 32 inch to about 1 / 16 inch per side, or from about 1 / 16 inch to about 1 / 8 inch per side, depending on factors such as catheter size, material stiffness of the catheter and absorbent element, and desired coating characteristics.
[0069] The applicator 100 includes an attachment mechanism 110 configured to secure the applicator body 102 to an introducer sheath or an endoscope. The attachment mechanism 110 may allow the applicator 100 to be coupled to the introducer sheath or endoscope such that a catheter may be advanced through the applicator 100 and into the introducer sheath or endoscope in a single motion.Attorney Docket No. 11583-028WO1
[0070] In some aspects, the attachment mechanism 110 may comprise a threaded coupling. A threaded coupling may provide a secure connection between the applicator body 102 and the introducer sheath or endoscope through engagement of complementary threads. In some cases, the attachment mechanism 110 may comprise a friction-fit collar. A friction-fit collar may provide a connection through frictional engagement between the applicator body 102 and the introducer sheath or endoscope. In some aspects, the attachment mechanism 110 may comprise a snap-fit coupling. A snap-fit coupling may provide a connection through engagement of complementary features that deflect during assembly and return to a locked position. In some cases, the attachment mechanism 110 may comprise a clamp. A clamp may provide a connection through compressive force applied to the introducer sheath or endoscope. The attachment mechanism 110 may comprise a threaded coupling, a friction-fit collar, a snap-fit coupling, a clamp, or a combination thereof.
[0071] The attachment mechanism 110 may be configured to secure the applicator body 102 to the introducer sheath or endoscope such that the internal lumen 104 is aligned with a lumen passing longitudinally through the introducer sheath or endoscope. Alignment of the internal lumen 104 with the lumen of the introducer sheath or endoscope may allow a catheter to pass through the applicator 100 and into the introducer sheath or endoscope without obstruction. In some cases, the attachment mechanism 110 may include alignment features that facilitate coaxial positioning of the internal lumen 104 relative to the lumen of the introducer sheath or endoscope.
[0072] The applicator 100 may optionally include at least one end cap 108 configured to retain the absorbent element 106 within the applicator body 102. The at least one end cap 108 may be positioned at one or both longitudinal ends of the applicator body 102 to maintain the absorbent element 106 in a desired position within the internal lumen 104 during storage, handling, and use. In some cases, the at least one end cap 108 may prevent displacement or extrusion of the absorbent element 106 from the internal lumen 104 when a catheter is advanced through the applicator 100.
[0073] In some aspects, the at least one end cap 108 may be reversibly attachable to the applicator body 102. Reversible attachment may allow the at least one end cap 108 to be removed from the applicator body 102 and subsequently reattached. In some cases, reversible attachment may be achieved through a friction fit, a snap fit, a threaded engagement, or a bayonet coupling between the at least one end cap 108 and the applicator body 102. Reversible attachment may allow a clinician to remove the at least one end cap 108 to access the internalAttorney Docket No. 11583-028WO1
[0074] lumen 104 for saturation of the absorbent element 106 with the liquid, and to reattach the at least one end cap 108 after saturation.
[0075] In some cases, the at least one end cap 108 may be longitudinally divisible. Longitudinal divisibility of the at least one end cap 108 may allow the at least one end cap 108 to be separated and removed from around a catheter after the catheter has been advanced through the applicator 100, without requiring withdrawal of the catheter. In some aspects, the at least one end cap 108 may include a splitting feature, such as a score line, a living hinge, or a weakened region, to facilitate longitudinal division of the at least one end cap 108. Longitudinal divisibility of the at least one end cap 108 may complement the longitudinal divisibility of the applicator body 102, allowing the enthe applicator 100 to be removed from around the catheter after catheter placement.
[0076] Optionally, the applicator 100 may further comprise a detachable cap sized to seal a distal end 116 of the internal lumen 104. The distal end 116 may correspond to the end of the applicator body 102 configured to attach to an introducer sheath or an endoscope. The detachable cap may maintain sterility of the internal lumen 104 and the absorbent element 106 during storage and prior to use. In some cases, the detachable cap may prevent evaporation or leakage of the liquid from the internal lumen 104 when the absorbent element 106 is pre-saturated with the liquid. The detachable cap may be removed prior to attachment of the applicator 100 to the introducer sheath or endoscope.
[0077] The applicator 100 may be configured to apply various liquids to the external surface of a catheter. The liquid may comprise a lubricating fluid, an antimicrobial solution, an anticoagulant solution, saline, or a combination thereof. In some cases, the liquid may comprise a heparinized solution for anticoagulant purposes. The selection of liquid may depend on the clinical application, the type of catheter, and the desired surface properties following application.
[0078] In some aspects, the liquid may comprise a liquid perfluorocarbon. Liquid perfluorocarbons may provide lubricity and may reduce biological adhesion on catheter surfaces. In some cases, the liquid perfluorocarbon may comprise perfluorotributylamine, perfluorooctyl bromide, perfluorodecalin, perfluoroperhydrophenanthrene, perfluorohexane, perfluorotripropylamine, dichloroperfluoro-n-octane, perfluoromethylcyclohexane, perfluorooctane, pentafluorophenyl, or a combination thereof. The selection of liquid perfluorocarbon may depend on factors such as viscosity, volatility, biocompatibility, and the intended duration of catheter placement.Attorney Docket No. 11583-028WO1
[0079] In some aspects, the liquid may comprise polydimethylsiloxane (PDMS) oil. PDMS oil may provide lubricating properties and may form a coating on the catheter surface that reduces friction during insertion and placement. In some cases, the PDMS oil may have a viscosity from about 10 centipoise to about 10,000 centipoise. The viscosity of the PDMS oil may be selected based on factors such as the desired coating thickness, the absorption characteristics of the absorbent element 106, and the rate of catheter advancement through the applicator 100.
[0080] In some cases, the liquid may comprise combinations of the foregoing liquids. For example, the liquid may comprise a lubricating fluid combined with an antimicrobial solution to provide both lubricity and antimicrobial properties to the catheter surface. The applicator 100 may accommodate liquids having a range of viscosities and compositions, allowing clinicians to select liquids appropriate for specific clinical applications.
[0081] The applicator 100 may be configured for use with various types of catheters. In some aspects, the catheter may comprise a vascular access catheter. Vascular access catheters may be used to provide access to the vascular system for administration of fluids, medications, or blood products. In some cases, the catheter may comprise a central venous catheter. Central venous catheters may be placed in large veins such as the internal jugular vein, subclavian vein, or femoral vein to provide vascular access for extended periods. In some aspects, the catheter may comprise a dialysis catheter. Dialysis catheters may be used to provide vascular access for hemodialysis procedures. In some cases, the catheter may comprise a stent delivery catheter. Stent delivery catheters may be used to deliver and deploy stents within blood vessels or other body lumens.
[0082] In addition to catheters, the applicator 100 may be configured for use with other medical devices. In some aspects, the applicator 100 may be configured for use with stents. Stents may be advanced through the internal lumen 104 such that the absorbent element 106 contacts an external surface of the stent and applies the liquid to the external surface of the stent. In some cases, the applicator 100 may be configured for use with guidewires. Guidewires may be advanced through the internal lumen 104 such that the absorbent element 106 contacts an external surface of the guide wire and applies the liquid to the external surface of the guidewire. The internal lumen 104 may be sized to accommodate the diameter of the stent, guidewire, or other medical device.
[0083] In some aspects, the external surface of the catheter may comprise a roughened solid surface. A roughened solid surface may include surface features such as micro-scale or nano-Attorney Docket No. 11583-028WO1
[0084] scale textures, pores, or irregularities that increase surface area relative to a smooth surface. In some cases, the roughened solid surface may be formed through mechanical treatment, chemical etching, plasma treatment, or deposition of textured coatings on the catheter surface.
[0085] When the liquid comprises a lubricating fluid, applying the liquid absorbed by the absorbent element 106 to the external surface of the catheter may comprise forming a lubricating fluid layer adhering to and preferentially wetting the roughened solid surface to form a slippery liquid surface over the roughened solid surface. The lubricating fluid layer may be retained within the surface features of the roughened solid surface, and the lubricating fluid may preferentially wet the roughened solid surface such that the lubricating fluid layer remains adhered to the catheter surface during insertion and placement. The slippery liquid surface formed over the roughened solid surface may reduce friction between the catheter and surrounding tissues or device components during advancement of the catheter. In some cases, the slippery liquid surface may reduce biological adhesion to the catheter surface following placement. In this manner, the applicators described herein can be used to apply a lubricating fluid to an appropriate surface to form a Slippery Liquid -Infused Porous Surface (SLIPS) on a catheter. Examples of such coatings are described, for example, in U. S. Patent No. 10,982,100, which is incorporated herein by reference in its entirety.
[0086] The applicator 100 may be configured as a single -use sterile device. In some aspects, the applicator 100 may be sterilized and packaged in a sterile barrier prior to use. Single-use configuration may reduce the risk of cross-contamination between patients and may simplify clinical workflows by eliminating the need for reprocessing or sterilization between uses. In some cases, the applicator 100 may be disposed of after a single use.
[0087] In some aspects, the applicator 100 may be configured as a reusable device for non-sterile environments. Reusable configurations may be suitable for applications where sterility is not a concern, such as laboratory settings, training environments, or non-clinical applications. In some cases, a reusable applicator 100 may be constructed from materials that withstand cleaning and repeated use. The absorbent element 106 in a reusable configuration may be replaceable, allowing the absorbent element 106 to be removed and replaced between uses while retaining the applicator body 102 and attachment mechanism 110.
[0088] The applicator 100 may be provided as part of a sterile kit. A sterile kit may comprise the applicator 100, a tray comprising a recess configured to temporarily hold the applicator 100, and a sterile barrier enclosing at least the applicator 100 and the tray. The sterile barrier mayAttorney Docket No. 11583-028WO1
[0089] maintain sterility of the applicator 100 and the tray during storage and transport prior to use. In some cases, the sterile barrier may comprise a peel pouch, a blister pack, a sealed wrapper, or other packaging configured to maintain a sterile environment.
[0090] In some aspects, the sterile kit may further comprise a catheter sized to pass through the internal lumen 104 of the applicator body 102. The catheter may be sized such that the external surface of the catheter contacts the absorbent element 106 during advancement through the internal lumen 104. In some cases, the sterile kit may further comprise an introducer sheath or an endoscope. The introducer sheath or endoscope may be configured to receive the applicator 100 via the attachment mechanism 110, allowing the catheter to be advanced through the applicator 100 and into the introducer sheath or endoscope in a single motion.
[0091] The tray may be configured to support the applicator 100 during preparation and saturation of the absorbent element 106 with the liquid. In some aspects, the recess of the tray may be configured to hold the applicator 100 in an upright orientation for saturating the absorbent element 106 with the liquid. Holding the applicator 100 in an upright orientation may allow a clinician to pour or inject the liquid into the internal lumen 104 to saturate the absorbent element 106 without spillage. In some cases, the upright orientation may position the applicator 100 such that the liquid flows into the internal lumen 104 and is absorbed by the absorbent element 106.
[0092] In some aspects, the recess may include an alignment feature configured to position the applicator 100 relative to a liquid source. The alignment feature may facilitate positioning of the applicator 100 such that the liquid may be introduced into the internal lumen 104 in a controlled manner. In some cases, the alignment feature may comprise a guide, a notch, a raised edge, or other structural feature that orients the applicator 100 relative to a syringe, vial, or other liquid source.
[0093] The recess may comprise various holder configurations to secure the applicator 100 within the tray. In some aspects, the recess may comprise a snap-fit holder. A snap-fit holder may engage the applicator body 102 through deflection and return of complementary features to retain the applicator 100 in position. In some cases, the recess may comprise a friction-fit holder. A friction-fit holder may retain the applicator 100 through frictional engagement between the recess and the applicator body 102. In some aspects, the recess may comprise a channel-shaped holder. A channel-shaped holder may receive the applicator body 102 within an elongatedAttorney Docket No. 11583-028WO1
[0094] channel that supports the applicator 100 along a longitudinal extent. The recess may comprise at least one of a snap-fit holder, a friction-fit holder, or a channel-shaped holder.
[0095] In some cases, the tray may include multiple recesses configured to hold the applicator 100 and other components of the sterile kit. The multiple recesses may be arranged to organize the applicator 100, the catheter, the introducer sheath or endoscope, and other components within the sterile kit for convenient access during clinical use.
[0096] Also described herein are methods of forming coatings using the applicators described herein. By way of example, a method of applying a liquid to an external surface of a catheter may comprise saturating the at least one absorbent element 106 of the applicator 100 with a liquid. As described above, the applicator 100 includes an applicator body 102 defining an internal lumen 104 sized to receive the catheter therethrough, at least one absorbent element 106 disposed within the internal lumen 104, and an attachment mechanism 110 configured to secure the applicator body 102 to an introducer sheath or an endoscope.
[0097] Saturating the at least one absorbent element 106 with the liquid may be performed in various ways. In some cases, the liquid may be poured into the applicator 100 to saturate the absorbent element 106. Pouring the liquid may comprise positioning the applicator 100 such that the internal lumen 104 is accessible and introducing the liquid into the internal lumen 104 from a container, vial, or other liquid source. In some aspects, the liquid may be introduced into the applicator 100 by flushing through the catheter into the applicator 100 rather than directly into the applicator 100. Flushing the liquid through the catheter may comprise connecting a syringe or other liquid delivery device to a proximal end of the catheter and advancing the liquid through the catheter such that the liquid exits a distal end of the catheter and enters the internal lumen 104 to saturate the absorbent element 106. In some cases, the liquid may be introduced by injection directly into the internal lumen 104 using a syringe or similar' device.
[0098] The method may further comprise securing the applicator 100 to an introducer sheath or an endoscope via the attachment mechanism 110. As described above, the attachment mechanism 110 may comprise a threaded coupling, a friction-fit collar, a snap-fit coupling, a clamp, or a combination thereof. Securing the applicator 100 to the introducer sheath or endoscope may position the applicator 100 such that the internal lumen 104 is aligned with a lumen passing longitudinally through the introducer sheath or endoscope.
[0099] The method may further comprise advancing at least a portion of the catheter through the internal lumen 104 of the applicator 100 such that the external surface of the catheter contacts theAttorney Docket No. 11583-028WO1
[0100] at least one absorbent element 106 and the liquid is applied to the external surface of the catheter during advancement through the internal lumen 104. As the catheter is advanced through the internal lumen 104, the absorbent element 106 may transfer the absorbed liquid to the external surface of the catheter. In some cases, the catheter may be advanced through the applicator 100 and into the introducer sheath or endoscope in a single motion.
[0101] In some aspects, the method may further comprise detaching the applicator 100 from the introducer sheath or the endoscope after the catheter is advanced. Detaching the applicator 100 may comprise disengaging the attachment mechanism 110 from the introducer sheath or endoscope.
[0102] The method may further comprise removing the applicator 100 from around the catheter. In some cases, the applicator body 102 may be longitudinally divisible to permit removal of the applicator body 102 from around a catheter received within the internal lumen 104. Removing the applicator 100 from around the catheter may comprise longitudinally dividing the applicator body 102 to remove the applicator body 102 from around the catheter. Longitudinal division of the applicator body 102 may be facilitated by a splitting mechanism 112, such as a score line, a peel tab, or a living hinge, as described above. In some aspects, the at least one end cap 108 may also be longitudinally divisible, allowing the at least one end cap 108 to be separated and removed from around the catheter along with the applicator body 102. Longitudinal division of the applicator body 102 and the at least one end cap 108 may allow the applicator 100 to be removed from around the catheter without requiring withdrawal of the catheter from the patient.
[0103] In some aspects, saturating the at least one absorbent element 106 with the liquid may comprise positioning the applicator body 102 in a recess of a tray configured to temporarily hold the applicator body 102 and introducing the liquid into the internal lumen 104 while the applicator body 102 is supported by the recess. As described above, the tray may be provided as part of a sterile kit and may include a recess configured to receive and support the applicator body 102. Positioning the applicator body 102 in the recess may stabilize the applicator 100 during the saturation process, allowing a clinician to introduce the liquid into the internal lumen 104 without manually holding the applicator body 102.
[0104] In some cases, the recess may hold the applicator body 102 in an upright orientation during introduction of the liquid. The upright orientation may position the applicator body 102 such that the internal lumen 104 extends vertically or substantially vertically, allowing the liquid to flow downward into the internal lumen 104 under the influence of gravity. Holding theAttorney Docket No. 11583-028WO1
[0105] applicator body 102 in the upright orientation during introduction of the liquid may facilitate absorption of the liquid by the absorbent element 106 and may reduce spillage or loss of the liquid during the saturation process. In some aspects, the upright orientation may allow a clinician to pour the liquid from a vial or container into the internal lumen 104, or to inject the liquid into the internal lumen 104 using a syringe, while the applicator body 102 remains stably supported by the recess.
[0106] During use, the applicator body 102, the absorbent element 106, the attachment mechanism 110, and other components of the applicator 100 may work together to apply the liquid to the external surface of a catheter. The overall workflow may proceed from saturation of the absorbent element 106 with the liquid, to attachment of the applicator 100 to an introducer sheath or endoscope, to application of the liquid to the catheter, and to removal of the applicator 100 from around the catheter.
[0107] In some aspects, a clinician may begin by saturating the absorbent element 106 with the liquid. As described above, saturation may be performed by pouring the liquid into the internal lumen 104, by flushing the liquid through the catheter into the applicator 100, or by injecting the liquid directly into the internal lumen 104. In some cases, the applicator body 102 may be positioned in a recess of a tray during saturation to stabilize the applicator 100 and facilitate introduction of the liquid. In some aspects, the absorbent element 106 may be pre-saturated with the liquid prior to sterilization and packaging, in which case the saturation step may be omitted at the point of use.
[0108] Following saturation, the clinician may secure the applicator 100 to an introducer sheath or an endoscope via the attachment mechanism 110. The attachment mechanism 110 may engage the introducer sheath or endoscope such that the internal lumen 104 of the applicator body 102 is aligned with a lumen passing longitudinally through the introducer sheath or endoscope.
[0109] Alignment of the internal lumen 104 with the lumen of the introducer sheath or endoscope may allow the catheter to pass through the applicator 100 and into the introducer sheath or endoscope without obstruction.
[0110] With the applicator 100 secured to the introducer sheath or endoscope, the clinician may advance the catheter through the internal lumen 104 of the applicator body 102. The absorbent element 106 is positioned within the internal lumen 104 to contact an external surface of the catheter as the catheter is advanced through the internal lumen 104. As the catheter passes through the internal lumen 104, the absorbent element 106 contacts the external surface of theAttorney Docket No. 11583-028WO1
[0111] catheter, thereby applying the liquid absorbed by the at least one absorbent element 106 to the external surface of the catheter. In some cases, the absorbent element 106 may extend along a longitudinal length of the internal lumen 104 sufficient to simultaneously contact a plurality of circumferential locations on the external surface of the catheter, which may apply a substantially uniform coating of the liquid to the external surface of the catheter. The catheter may be advanced through the applicator 100 and into the introducer sheath or endoscope in a single motion.
[0112] After the catheter has been advanced to a desired position, the clinician may detach the applicator 100 from the introducer sheath or endoscope by disengaging the attachment mechanism 110. In some cases, the applicator body 102 may be longitudinally divided to permit removal of the applicator body 102 from around the catheter without requiring withdrawal of the catheter from the patient. The splitting mechanism 112, such as a score line, a peel tab, or a living hinge, may facilitate longitudinal division of the applicator body 102. In some aspects, the at least one end cap 108 may also be longitudinally divisible, allowing the at least one end cap 108 to be separated and removed from around the catheter along with the applicator body 102. Removal of the applicator 100 from around the catheter may allow the catheter to remain in place within the patient while the applicator 100 is discarded or set aside.
[0113] A number of implementations have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the disclosure. Accordingly, other implementations are within the scope of the following claims.
Claims
Attorney Docket No. 11583-028WO1CLAIMSWhat is claimed is:
1. An applicator (100) for applying a liquid to an external surface of a catheter, comprising:an applicator body (102) defining an internal lumen (104) sized to receive the catheter therethrough;at least one absorbent element (106) disposed within the internal lumen, the absorbent element configured to absorb the liquid; andan attachment mechanism (110) configured to secure the applicator body to an introducer sheath or an endoscope;wherein the absorbent element is positioned to contact an external surface of the catheter as the catheter is advanced through the internal lumen, thereby applying the liquid absorbed by the at least one absorbent element to the external surface of the catheter.
2. The applicator of claim 1, wherein the applicator body (102) is longitudinally divisible to permit removal of the applicator body (102) from around a catheter received within the internal lumen (104).
3. The applicator of any one of claims 1-2, wherein the applicator body (102) further comprises a splitting mechanism (112) comprising at least one of a score line, a peel tab, or a living hinge.
4. The applicator of any one of claims 1-3, further comprising at least one end cap (108) configured to retain the absorbent element (106) within the applicator body (102).
5. The applicator of claim 4, wherein the at least one end cap (108) is reversibly attachable to the applicator body (102).
6. The applicator of any one of claims 4-5, wherein the at least one end cap (108) is longitudinally divisible.Attorney Docket No. 11583-028WO17. The applicator of any one of claims 1-6, wherein the absorbent element (106) is adhered to an inner surface (114) of the applicator body (102).
8. The applicator of any one of claims 1-7, wherein the attachment mechanism (110) comprises a threaded coupling, a friction-fit collar, a snap-fit coupling, a clamp, or a combination thereof.
9. The applicator of any one of claims 1-8, wherein the attachment mechanism (110) is configured to secure the applicator body (102) to the introducer sheath or endoscope such that the internal lumen (104) is aligned with a lumen passing longitudinally through the introducer sheath or endoscope.
10. The applicator of any one of claims 1-9, wherein the at least one absorbent element (106) comprises an open-cell foam, such as an open-cell polyurethane foam.
11. The applicator of any one of claims 1-10, wherein the at least one absorbent element (106) extends along a longitudinal length of the internal lumen (104) sufficient to simultaneously contact a plurality of circumferential locations on the external surface of the catheter to apply a substantially uniform coating of the liquid to the external surface of the catheter.
12. The applicator of any one of claims 1-11, wherein the at least one absorbent element (106) is pre-saturated with the liquid prior to sterilization and packaging of the applicator device.
13. The applicator of any one of claims 1-12, wherein the applicator body (102) is formed from a thermoplastic, such as polypropylene, polyvinyl chloride, polyethylene, polycarbonate, acrylonitrile butadiene styrene (ABS), or combinations thereof.
14. The applicator of any one of claims 1-13, wherein the liquid comprises a lubricating fluid, an antimicrobial solution, an anticoagulant solution, saline, or a combination thereof.Attorney Docket No. 11583-028WO115. The applicator of any one of claims 1-14, wherein the liquid comprises a liquid perfluorocarbon.
16. The applicator of claim 15, wherein the liquid perfluorocarbon comprises perfluorotributylamine, perfluorooctyl bromide, perfluorodecalin, perfluoroperhydrophenanthrene, perfluorohexane, perfluorotripropylamine, dichloroperfluoro-n- octane, perfluoromethylcyclohexane, perfluorooctane, pentafluorophenyl, or a combination thereof.
17. The applicator of any one of claims 1-14, wherein the liquid comprises polydimethylsiloxane (PDMS) oil, such as PDMS oil having a viscosity from about 10 centipoise to about 10,000 centipoise.
18. The applicator of any one of claims 1-17, wherein the external surface of the catheter comprises a roughened solid surface;wherein the liquid comprises a lubricating fluid; andwherein applying the liquid absorbed by the at least one absorbent element to the external surface of the catheter comprises forming a lubricating fluid layer adhering to and preferentially wetting the roughened solid surface to form a slippery liquid surface over the roughened solid surface.
19. The applicator of any one of claims 1-18, wherein the catheter comprises a vascular access catheter, a central venous catheter, a dialysis catheter, or a stent delivery catheter.
20. The applicator of any one of claims 1-19, wherein the applicator further comprises a detachable cap sized to seal a distal end (116) of the internal lumen (104).
21. The applicator of any one of claims 1-20, wherein the applicator is configured as a single-use sterile device.
22. A sterile kit comprising:an applicator defined by any one of claims 1-21;Attorney Docket No. 11583-028WO1a tray comprising a recess configured to temporarily hold the applicator; anda sterile barrier enclosing at least the applicator and the tray.
23. The kit of claim 22, wherein the kit further comprises a catheter sized to pass through the internal lumen of the applicator body and an introducer sheath or an endoscope,24. The kit of any one of claims 22-23, wherein the recess is configured to hold the applicator device in an upright orientation for saturating the absorbent element with the liquid.
25. The kit of any one of claims 22-24, wherein the recess includes an alignment feature configured to position the applicator device relative to a liquid source.
26. The kit of any one of claims 22-25, wherein the recess comprises at least one of a snap-fit holder, a friction-fit holder, or a channel-shaped holder.
27. A method of applying a liquid to an external surface of a catheter, the method comprising:saturating the at least one absorbent element of an applicator device defined by any one of claims 1-21 with a liquid;securing the applicator to an introducer sheath or an endoscope via the attachment mechanism; andadvancing at least a portion of the catheter through the internal lumen of the applicator such that the external surface of the catheter contacts the at least one absorbent element and the liquid is applied to the external surface of the catheter during advancement through the internal lumen.
28. The method of claim 27, further comprising:detaching the applicator from the introducer sheath or the endoscope after the catheter is advanced; andremoving the applicator from around the catheter.Attorney Docket No. 11583-028WO129. The method of claim 28, wherein the applicator body (102) is longitudinally divisible to permit removal of the applicator body (102) from around a catheter received within the internal lumen (104); andwherein removing the applicator from around the catheter comprises longitudinally dividing the applicator body to remove the applicator body from around the catheter.
30. The method of any one of claims 27-29, wherein saturating the at least one absorbent element with the liquid comprises positioning the applicator body in a recess of a tray configured to temporarily hold the applicator body and introducing the liquid into the internal lumen while the applicator body is supported by the recess.
31. The method of claim 30, wherein the recess holds the applicator body in an upright orientation during introduction of the liquid.
